T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination
Abstract Background The SARS-CoV-2 index-virus nanoparticle protein vaccine (NVX-CoV2373) induces humoral and cell-mediated immune responses that protect against severe COVID-19, including from SARS-CoV-2 variants. Limited information exists on NVX-CoV2373–induced cell-mediated immune responses to a...
Saved in:
| Main Authors: | William C. McMahon, Gaurav Kwatra, Marta C. Nunes, Alane Izu, Anthonet L. Koen, Johann Greffrath, Sharon Shalekoff, Caroline T. Tiemessen, Vivek Shinde, Chijioke Bennett, Shabir A. Madhi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-025-00941-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
by: Alane Izu, et al.
Published: (2025-12-01) -
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants
by: Busra Kaplan, et al.
Published: (2025-02-01) -
The Pandemic is in Progress: Long Covid, Omicrons, Vaccination and Vaccines
by: E. P. Kharchenko
Published: (2022-11-01) -
Clinical characteristics and booster vaccine effectiveness of the Omicron variant
by: Lijun Sun, et al.
Published: (2024-11-01) -
Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells.
by: Yanshan Zhu, et al.
Published: (2022-08-01)